Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
0.8417
+0.0219 (2.67%)
May 6, 2026, 12:46 PM EDT - Market open
Enlivex Employees
Enlivex had 34 employees as of December 31, 2025. The number of employees decreased by 37 or -52.11% compared to the previous year.
Employees
34
Change
-37
Growth
-52.11%
Revenue / Employee
n/a
Profits / Employee
$36,339,059
Market Cap
202.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 34 | -37 | -52.11% |
| Dec 31, 2021 | 71 | 21 | 42.00% |
| Dec 31, 2020 | 50 | 14 | 38.89% |
| Dec 31, 2019 | 36 | 5 | 16.13% |
| Dec 31, 2018 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Karyopharm Therapeutics | 228 |
| Humacyte | 184 |
| Tonix Pharmaceuticals Holding | 142 |
| OmniAb | 89 |
| Precision BioSciences | 68 |
| Korro Bio | 58 |
| OnKure Therapeutics | 45 |
ENLV News
- 6 days ago - Enlivex Treasury Portfolio Update: Listing of the RAIN Token on HTX, a Leading Cryptocurrency Exchange - GlobeNewsWire
- 8 days ago - Enlivex Treasury Update: Total RAIN Holdings Rise to 78,819,756,062 Tokens as of April 27, 2026, Representing an Aggregated Value of $567 Million - GlobeNewsWire
- 13 days ago - Enlivex to Present Phase IIa 3-month and 6-month Data of Allocetra at OARSI 2026 World Congress - GlobeNewsWire
- 15 days ago - Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis - GlobeNewsWire
- 4 weeks ago - Ondo Global Markets Tokenizes Enlivex's Ordinary Shares - GlobeNewsWire
- 5 weeks ago - Enlivex Rain Update: Rain Launches an OpenClaw and AI Agent Interface Allowing Anyone To Create A Prediction Market Via A Single Prompt - GlobeNewsWire
- 6 weeks ago - Enlivex Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - Enlivex Reports Full-Year 2025 Results: Profit (Net Income) of $1.23 Billion and Diluted Earnings Per Share (EPS) of $25.48 - GlobeNewsWire